How to Evaluate the Benefit-Risk Profile of Newly Marketed Drugs
Creator
Naldi, L
Bibliographic Citation
Annales de dermatologie et de vénéréologie 2010 Apr; 137(4): 264-6, 261-3
Date
2010-04Subject
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Priorities in the Benefit-Risk Assessment of New Drugs
Venning, G.R. (1984-06)